← LibraryThe Cartilage Guide

Review · 2001

Vascular mechanisms in osteoarthritis

Ghosh P, Cheras PA · Best Practice & Research. Clinical Rheumatology

Preclinicalcounts toward this tier

The argument that gives an anticoagulant a reason to be an arthritis drug: cartilage-derived antigens provoke synovitis, whose pro-coagulant mediators tip subchondral vessels toward hypercoagulation, hypofibrinolysis and ischaemic bone necrosis — from which the authors predict that agents that are simultaneously antithrombotic, lipid-lowering and anti-inflammatory should slow OA.

Population
Narrative review of subchondral vascular pathology in osteoarthritis
Intervention
n/a
Comparator
n/a
Limitations
A hypothesis paper by PPS's developer, arguing for the drug class he developed; the vascular model remains the least directly tested leg of the mechanism, and the trial designed to test it in humans — MaRVeL, which enrols only people with dyslipidaemia — has not reported.

Cited by

1 entry references this study